Why Switzerland Why Switzerland Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape
Life sciences Western Switzerland research teams explore new strategy to boost cancer immunotherapy 14 April 2025
Headquarters Toblerone strengthens its Swiss roots with CHF 65 million investment in Bern 14 April 2025
Business environment Switzerland expands international research cooperation with four new ERIC memberships 9 April 2025
Life sciences Life sciences Novigenix secures EUR 1.8 million to scale precision oncology platform 9 April 2025
Business environment Switzerland regains access to major EU programs under new agreement 9 April 2025
Press Releases Foreign Direct Investment 2024: A Winning Strategy for Western Switzerland 8 April 2025
Life sciences CHUV’s new Children’s Hospital enhances pediatric care in Western Switzerland 8 April 2025